US healthcare packaging solutions provider Nelipak has completed the acquisition of Merrill’s Packaging, expanding its position in key healthcare manufacturing hubs.
Financial terms of the deal were not disclosed.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Merrill’s Packaging focuses on custom thermoformed packaging for medical device, pharmaceutical, life science and other technically demanding sectors.
Its portfolio also includes related offerings such as die-cut pouches and mounting cards, alongside design, development and tooling services.
The business runs ISO 13485-certified manufacturing facilities in Burlingame, California, and Alajuela, Costa Rica.
Merrill’s Packaging CEO Rick Schulz stated: “This is an incredible growth opportunity for Merrill’s employees and customers.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“With access to Nelipak’s global capabilities and broad suite of rigid and flexible product solutions, we look forward to exploring new ways to deliver value to our customers.”
Established in 1961, Merrill’s Packaging has evolved into a specialist in custom thermoforming.
Notable developments in its growth include its move into the Costa Rican market in 2010 and the launch of a larger facility in the country in 2024.
Nelipak CEO Pat Chambliss added: “We are excited to welcome the Merrill’s Packaging team to the Nelipak family.
“We have tremendous respect for their history of growth, innovation, and customer focus. Nelipak will benefit from Merrill’s dedicated and talented team, custom thermoforming capabilities, strong customer relationships, and well-located production sites in California and Costa Rica.”
Nelipak supplies rigid and flexible sterile-barrier packaging for healthcare applications, serving medical device, diagnostic and pharmaceutical drug delivery markets as well as other demanding use cases.
The company has a workforce of more than 1,600 and operates 14 facilities globally: eight in the Americas, five in Europe and one in Asia.
